McNeill Jonathan
CIK 0001824673 Name as filed on the most recent filing
Filed as McNeill Jonathan (19)
35 transaction lines · from 19 filings · filed 2021-09-22 to 2026-06-23 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
35 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-22 |
Crescent Biopharma, Inc. CBIO |
S, Open-market sale | 20,549 disposed | 17.99 | 369,676.51 | Form 4, filing 0001628280-26-044885 | |
| 2024-08-19 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 2,400 disposed | 45.01 | 108,024.00 | Form 4, filing 0000950170-24-099127 | |
| 2024-08-19 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 305 disposed | 46.00 | 14,030.00 | Form 4, filing 0000950170-24-099127 | |
| 2024-06-11 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 1,823 disposed | 31.34 | 57,132.82 | Form 4, filing 0000950170-24-072151 | |
| 2024-05-16 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 2,279 disposed | 28.20 | 64,267.80 | Form 4, filing 0000950170-24-062075 | |
| 2024-05-16 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 495 disposed | 28.59 | 14,152.05 | Form 4, filing 0000950170-24-062075 | |
| 2024-03-11 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 17,825 disposed | 25.48 | 454,181.00 | Form 4, filing 0000950170-24-030484 | |
| 2024-03-11 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 1,776 disposed | 25.71 | 45,660.96 | Form 4, filing 0000950170-24-030484 | |
| 2024-03-08 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 54,648 disposed | 26.72 | 1,460,194.56 | Form 4, filing 0000950170-24-030484 | |
| 2024-03-08 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 34,663 disposed | 25.46 | 882,519.98 | Form 4, filing 0000950170-24-030484 | |
| 2024-03-08 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 689 disposed | 27.31 | 18,816.59 | Form 4, filing 0000950170-24-030484 | |
| 2024-03-07 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 2,434 disposed | 25.85 | 62,918.90 | Form 4, filing 0000950170-24-029607 | |
| 2024-03-01 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 14,103 disposed | 28.25 | 398,409.75 | Form 4, filing 0000950170-24-024299 | |
| 2024-03-01 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 8,715 disposed | 29.06 | 253,257.90 | Form 4, filing 0000950170-24-024299 | |
| 2024-03-01 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 1,442 disposed | 29.70 | 42,827.40 | Form 4, filing 0000950170-24-024299 | |
| 2024-02-29 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 4,268 disposed | 27.50 | 117,370.00 | Form 4, filing 0000950170-24-024299 | |
| 2024-01-26 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 19,822 disposed | 24.52 | 486,035.44 | Form 4, filing 0000950170-24-008062 | |
| 2024-01-26 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 178 disposed | 25.14 | 4,474.92 | Form 4, filing 0000950170-24-008062 | |
| 2024-01-04 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 2,009 disposed | 18.04 | 36,242.36 | Form 4, filing 0000950170-24-002278 | |
| 2024-01-03 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 10,300 disposed | 19.03 | 196,009.00 | Form 4, filing 0000950170-24-002278 | |
| 2024-01-03 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 7,691 disposed | 18.34 | 141,052.94 | Form 4, filing 0000950170-24-002278 | |
| 2024-01-02 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 11,900 disposed | 13.10 | 155,890.00 | Form 4, filing 0000950170-24-002278 | |
| 2023-12-11 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 1,245 disposed | 10.72 | 13,346.40 | Form 4, filing 0001209191-23-058330 | |
| 2023-09-18 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 1,261 disposed | 9.41 | 11,866.01 | Form 4, filing 0001209191-23-050173 | |
| 2023-09-12 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 1,266 disposed | 10.41 | 13,179.06 | Form 4, filing 0001209191-23-049360 | |
| 2023-06-13 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 1,259 disposed | 12.43 | 15,649.37 | Form 4, filing 0001209191-23-037167 | |
| 2023-06-12 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 1,000 disposed | 13.00 | 13,000.00 | Form 4, filing 0001209191-23-037167 | |
| 2023-03-14 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 1,209 disposed | 13.33 | 16,115.97 | Form 4, filing 0001209191-23-018981 | |
| 2023-03-13 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 1,000 disposed | 13.00 | 13,000.00 | Form 4, filing 0001209191-23-018981 | |
| 2023-01-18 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 10,000 disposed | 14.03 | 140,300.00 | Form 4, filing 0001209191-23-004345 | |
| 2023-01-09 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 30,150 disposed | 11.57 | 348,835.50 | Form 4, filing 0001209191-23-003013 | |
| 2022-12-12 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 472 disposed | 10.87 | 5,130.64 | Form 4, filing 0001209191-22-060972 | |
| 2022-03-11 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 481 disposed | 8.73 | 4,199.13 | Form 4, filing 0001209191-22-018536 | |
| 2021-09-21 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 729 disposed | 16.11 | 11,744.19 | Form 4, filing 0001209191-21-057325 | |
| 2021-09-20 |
Dyne Therapeutics, Inc. DYN |
S, Open-market sale | 545 disposed | 15.61 | 8,507.45 | Form 4, filing 0001209191-21-057325 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 35
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. McNeill Jonathan, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001824673
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6